Why is Medicamen Biotec falling/rising?

As of 24-Jun, Medicamen Biotech Ltd's stock price is currently at Rs 395.00, reflecting a decrease of Rs 9.0 or 2.23%. The stock has underperformed significantly, with a 1-week return of -3.67% and a 1-month return of -8.51%. It is also trading close to its 52-week low, just 4.56% above Rs 377. Today's performance indicates a day’s low of Rs 392.5, and the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Despite a rise in delivery volume by 87.74% against the 5-day average, the overall sentiment remains negative, as there are no positive factors noted to counterbalance the stock's decline.
Broader market context shows that while Medicamen Biotech's stock has fallen, the benchmark Sensex has gained 0.58% over the past week. This stark contrast highlights the stock's underperformance relative to the broader market, with a year-to-date decline of 22.43% compared to the Sensex's 5.01% increase. The liquidity of the stock remains adequate for trading, but the overall negative returns over various periods suggest a challenging environment for Medicamen Biotech, further exacerbated by its recent price movements.